Checkpoint Therapeutics Inc
NASDAQ:CKPT

Watchlist Manager
Checkpoint Therapeutics Inc Logo
Checkpoint Therapeutics Inc
NASDAQ:CKPT
Watchlist
Price: 4.26 USD 0.71% Market Closed
Market Cap: 370.7m USD

Wall Street
Price Targets

CKPT Price Targets Summary
Checkpoint Therapeutics Inc

There are no price targets for CKPT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Checkpoint Therapeutics Inc Competitors:
Price Targets
NTRA
Natera Inc
7% Upside
SBTX
SkinBioTherapeutics PLC
94% Upside
ADAG
Adagene Inc
426% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
50% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
27% Upside
SYNACT
SynAct Pharma AB
15% Upside
FOLD
Amicus Therapeutics Inc
14% Upside
CHRS
Coherus BioSciences Inc
301% Upside

Revenue
Forecast

Revenue Estimate
Checkpoint Therapeutics Inc

For the last 8 years the compound annual growth rate for Checkpoint Therapeutics Inc's revenue is -40%. The projected CAGR for the next 4 years is 888%.

-40%
Past Growth
888%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Checkpoint Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
Checkpoint Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CKPT's stock price target?
Not Available

CKPT doesn't have any price targets made by Wall Street professionals.

What is Checkpoint Therapeutics Inc's Revenue forecast?
Projected CAGR
888%

For the last 8 years the compound annual growth rate for Checkpoint Therapeutics Inc's revenue is -40%. The projected CAGR for the next 4 years is 888%.

Back to Top